Review of oral cholera vaccines: Efficacy in young children

Infection and Drug Resistance

Volumn 4, Issue 1, 2011, Pages 155-160

  Aumatell, Cristina Masuet ^a   Torrell, Jm Ramon ^a   Zuckerman, Jane N ^b  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Children; Efficacy; Oral cholera vaccine

Indexed keywords

CHOLERA VACCINE; PLACEBO;

ACTIVE IMMUNIZATION; CHOLERA; DRUG EFFICACY; DRUG SAFETY; HUMAN; IMMUNOGENICITY; INFECTION PREVENTION; INFECTION RESISTANCE; REVIEW; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

EID: 84860444711     PISSN: 11786973     EISSN: None     Source Type: Journal    
DOI: 10.2147/IDR.S10339     Document Type: Review

References (33)

1. World Health Organization. Cholera vaccines: WHO position paper. Wkly Epidemiol Rec. 2010;85(13):117-128.
2. Zuckerman JN, Rombo L, Fisch A. The true burden and risk of cholera: implications for prevention and control. Lancet Infect Dis. 2007;7(8):521-530.
3. Deen JL, von Seidlein L, Sur D, et al. The high burden of cholera in children: comparison of incidence from endemic areas in Asia and Africa. PLoS Negl Trop Dis. 2008;2(2):e173.
4. Tacket CO, Sack DA. Cholera vaccines. In: Plotkin SA, Orenstein WA, Offit PA, editors. Vaccines. 5th ed. Philadelphia, PA: Saunders Elsevier; 2008:127-138.
5. Hill DR, Ford L, Lalloo DG. Oral cholera vaccines: use in clinical practice. Lancet Infect Dis. 2006;6(6):361-373.
6. Torrell JMR, Aumatell CM, Ramos SM, Mestre LG, Salas CM. Reduction in travellers' diarrhoea by WC/rBS oral cholera vaccine in young, high-risk travellers. Vaccine. 2009;27(30):4074-4077.
7. Sinclair D, Abba K, Zaman K, Qadri F, Graves PM. Oral vaccines for preventing cholera [review]. Cochrane Database Syst Rev. 2011;3:CD008603.
8. Orenstein WA, Bernier RH, Dondero TJ, et al. Field evaluation of vaccine efficacy. Bull World Health Organ. 1985;63(6):1055-1068.
9. Clemens JD, Harris JR, Sack DA, et al. Field trial of oral cholera vaccines in Bangladesh. Southeast Asian J Trop Med Public Health. 1988;19(3):417-422.
10. Clemens JD, Sack DA, Chakraborty J, et al. Field trial of oral cholera vaccines in Bangladesh: evaluation of anti-bacterial and anti-toxic breast-milk immunity in response to ingestion of the vaccines. Vaccine. 1990;8(5):469-472.
11. Clemens JD, Sack DA, Harris JR, et al. ABO blood groups and cholera: new observations on specificity of risk and modifications of vaccine efficacy. J Infect Dis. 1989;159(4):770-773.
12. Clemens JD, Sack DA, Harris JR, et al. Field trial of oral cholera vaccines in Bangladesh. Lancet. 1986;2(8499):124-127.
13. Clemens JD, Sack DA, Harris JR, et al. Impact of subunit killed wholecell and killed whole-cell-only oral vaccines against cholera upon treated diarrhoeal illness and mortality in an area endemic for cholera. Lancet. 1988;1(8599):1375-1379.
14. Clemens JD, Sack DA, Harris JR, et al. Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up. Lancet. 1990;335(8684):270-273.
15. van Loon FP, Clemens JD, Chakraborty J, et al. Field trial of inactivated oral vaccines in Bangladesh: results from 5 years of follow-up. Vaccine. 1996;14(2):162-166.
16. Begue RE, Castellares G, Ruiz R, et al. Community-based assessment of safety and immunogenicity of the whole cell plus recombinant b subunit (WC/rBS) oral cholera vaccine in Peru. Vaccine. 1995;13(7):691-694.
17. Chen Q, Yu S, Wang Y. Community trial for safety and immunogenicity of oral-administered lyophilized rBS-WC cholera vaccine. Zhonghua Yu Fang Yi Xue Za Zhi. 1996;30(6):330-333. Chinese.
18. Concha A, Giraldo A, Castañeda E, et al. Safety and immunogenicity of oral killed whole cell recombinant B subunit cholera vaccine in Barranquilla, Colombia. Bull Pan Am Health Organ. 1995;29(4):312-321.
19. Hallander HO, Paniagua M, Espinoza F, et al. Calibrated serological techniques demonstrate significant different serum response rates to an oral killed cholera vaccine between Swedish and Nicaraguan children. Vaccine. 2002;21(1-2):138-145.
20. Kanungo S, Paisley A, Lopez AL, et al. Immune responses following one and two doses of the reformulated, bivalent, killed, whole-cell, oral cholera vaccine among adults and children in Kolkata, India: a randomized, placebo-controlled trial. Vaccine. 2009;27(49):6887-6893.
21. Lagos R, Avendaño A, Prado V, et al. Attenuated live cholera vaccine strain CVD 103-HgR elicits significantly higher serum vibriocidal antibody titers in persons of blood group O. Infect Immun. 1995;63(2):707-709.
22. Mahalanabis D, Lopez AL, Sur D, et al. A randomized, placebocontrolled trial of the bivalent killed, whole-cell, oral cholera vaccine in adults and children in a cholera endemic area in Kolkata, India. PLoS One. 2008;3(6):e2323.
23. Qadri F, Chowdhury MI, Faruque SM, et al. Peru-15, a live attenuated oral cholera vaccine, is safe and immunogenic in Bangladeshi toddlers and infants. Vaccine. 2007;25(2):231-238.
24. Richie EE, Punjabi NH, Sidharta YY, et al. Efficacy trial of single dose live oral vaccine CVD 103-HgR in North Jakarta, Indonesia, a cholera endemic area. Vaccine. 2000;18(22):2399-2410.
25. Simanjuntak CH, O'Hanley P, Punjabi NH, et al. Safety, immunogenicity, and transmissibility of single-dose live oral cholera vaccine strain CVD 103-HgR in 24-to 59-month-old Indonesian children. J Infect Dis. 1993;168(5):1169-1176.
26. Suharyono, Simanjuntak C, Witham N, et al. Safety and immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR in 5-9-year-old Indonesian children. Lancet. 1992;340(8821):689-694.
27. Clemens JD, Harris JR, Sack DA, et al. Field trial of oral cholera vaccine in Bangladesh: results from one year of follow-up. J Infect Dis. 1988;158(1):60-69.
28. Taylor DN, Cardenas V, Sanchez JL, et al. Two-year study of the protective efficacy of the oral whole cell plus recombinant B subunit cholera vaccine in Peru. J Infect Dis. 2000;181(5):1667-1673.
29. Trach DD, Clemens JD, Ke NT, et al. Field trial of a locally produced, killed, oral cholera vaccine in Vietnam. Lancet. 1997;349(9047):231-235.
30. Sur D, Lopez AL, Kanungo S, et al. Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial. Lancet. 2009;374(9702):1694-1702.
31. Levine MM. Immunogenicity and eff icacy of oral vaccines in developing countries: lessons from a live cholera vaccine. BMC Biol. 2010;8:129-138.
32. Sack DA. Herd protection and herd amplification in cholera. J Health Popul Nutr. 2006;24(1):1-5.
33. Ali M, Emch M, von Seidlein L, et al. Herd immunity conferred by killed oral cholera vaccines in Bangladesh: a reanalysis. Lancet. 2005;366(9479):44-49.